# clm_87A3CD3A03BE

subject: Amgen (/record/amgen.md)  
predicate: quarterly_operating_income  
value: 1,921,000,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-04-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_5A3FD4672B1E  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly operating income: 1,921,000,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_87A3CD3A03BE, https://asof.is/claim/clm_87A3CD3A03BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815423000029/0000318154-23-000029-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2023-04-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815423000029/0000318154-23-000029-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-04-28)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_operating_income | 2,660,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_87A3CD3A03BE](/claim/clm_87A3CD3A03BE.md) | [clm_78C2CEAEC57D](/claim/clm_78C2CEAEC57D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.